NCT03278210

Brief Summary

The main goal of this study is to evaluate the additional value of EEG-fMRI method in the presurgical evaluation of focal intractable epilepsy. To consider a patient for surgery, the main difficulty is to define accurately the epileptogenic zone. This definition is complex and is often supported by several types of exploration (MRI, FDG PET, neuropsychological testing, video-EEG...). In this study we will evaluate the adding value of the simultaneous recording of EEG and fMRI in the epileptogenic zone definition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 13, 2011

Completed
5.7 years until next milestone

First Submitted

Initial submission to the registry

January 4, 2017

Completed
8 months until next milestone

First Posted

Study publicly available on registry

September 11, 2017

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2020

Completed
Last Updated

December 3, 2025

Status Verified

December 1, 2025

Enrollment Period

9 years

First QC Date

January 4, 2017

Last Update Submit

December 2, 2025

Conditions

Keywords

EEG-fMRIbrain imagingpresurgical evaluationepilepsy surgery

Outcome Measures

Primary Outcomes (1)

  • Efficacity of surgery measured by the International League Against Epilepsy (ILAE) scale

    A score between 1-4 reflects an improvement in epilepsy and between 5-6 a lack of improvement.

    1 year after surgery

Secondary Outcomes (5)

  • Number of patients who finally underwent a surgery after EEG-fMRI results even if they were considered as non surgical after standard presurgical evaluation

    1 year after surgery

  • Percentage of inter-ictal and ictal discharges for localizing the epileptogenic zone by EEG

    1 year after surgery

  • Quality of life score (QOLIE 31)

    1 year after surgery

  • Number of patients who finally underwent a surgery after EEG-fMRI results on SEEG implantation strategy after standard presurgical evaluation(concluded to a surgical management or an SEEG)

    1 year after surgery

  • Distinction of patients according to the type of their epilepsy: temporal / extra temporal.

    1 year after surgery

Study Arms (2)

with EEG-fMRI data

EEG-fMRI was performed during the pre surgical evaluation, and its results were provided to the clinicians before surgery planification. The final surgery strategy was decided with EEG-fMRI results.

without EEG-fMRI data

EEG-fMRI was performed during the pre surgical evaluation, but clinicians were blinded to the results. The final surgery strategy was decided without EEG-fMRI results.

Eligibility Criteria

Age8 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients followed for a focal intractable epilepsy and engaged in a pre surgical evaluation.

You may qualify if:

  • \> 8 years old
  • intractable focal epilepsy
  • presurgical evaluation or "phase 1" planified
  • with focal EEG activity : more than 3 EEG interictal epileptic events per hour
  • patient and/or legal representant given their written consent for their participation in the study

You may not qualify if:

  • MRI contraindication
  • pregnancy
  • uncomfortable prolonged lying position
  • frequent primary or secondary generalised seizure with tonic clonic movements (\>2 per week)
  • previous epilepsy surgery
  • important mental retardation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Roger Salengro, CHRU de Lille

Lille, France

Location

MeSH Terms

Conditions

Drug Resistant EpilepsyEpilepsies, Partial

Condition Hierarchy (Ancestors)

EpilepsyBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Louise Tyvaert, MD, PhD

    University Hospital, Lille

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 4, 2017

First Posted

September 11, 2017

Study Start

April 13, 2011

Primary Completion

April 1, 2020

Study Completion

April 1, 2020

Last Updated

December 3, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations